298 related articles for article (PubMed ID: 34687394)
1. Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathy.
Deng NH; Luo W; Gui DD; Yan BJ; Zhou K; Tian KJ; Ren Z; Xiong WH; Jiang ZS
Mol Cell Biochem; 2022 Jan; 477(1):255-265. PubMed ID: 34687394
[TBL] [Abstract][Full Text] [Related]
2. Protective role of hydrogen sulfide against diabetic cardiomyopathy by inhibiting pyroptosis and myocardial fibrosis.
Liu M; Zeng C; Zhang Y; Xin Y; Deng S; Hu X
Biomed Pharmacother; 2024 Jun; 175():116613. PubMed ID: 38657502
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid treatment improves adverse cardiac remodelling in the diabetic heart - The role of cardiac hydrogen sulfide-synthesizing enzymes.
Dugbartey GJ; Wonje QL; Alornyo KK; Adams I; Diaba DE
Biochem Pharmacol; 2022 Sep; 203():115179. PubMed ID: 35853498
[TBL] [Abstract][Full Text] [Related]
4. New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H
Guo R; Wu Z; Jiang J; Liu C; Wu B; Li X; Li T; Mo H; He S; Li S; Yan H; Huang R; You Q; Wu K
Mech Ageing Dev; 2017 Mar; 162():46-52. PubMed ID: 27871808
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide regulates SERCA2a SUMOylation by S-Sulfhydration of SENP1 to ameliorate cardiac systole-diastole function in diabetic cardiomyopathy.
Peng S; Wang M; Zhang S; Liu N; Li Q; Kang J; Chen L; Li M; Pang K; Huang J; Lu F; Zhao D; Zhang W
Biomed Pharmacother; 2023 Apr; 160():114200. PubMed ID: 36750014
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen Sulfide Attenuates High Glucose-induced Myocardial Injury in Rat Cardiomyocytes by Suppressing Wnt/beta-catenin Pathway.
Zhang M; Ye M
Curr Med Sci; 2019 Dec; 39(6):938-946. PubMed ID: 31845225
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.
Kar S; Kambis TN; Mishra PK
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1237-H1252. PubMed ID: 30925069
[TBL] [Abstract][Full Text] [Related]
9. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.
Wang L; Cai Y; Jian L; Cheung CW; Zhang L; Xia Z
Cardiovasc Diabetol; 2021 Jan; 20(1):2. PubMed ID: 33397369
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen Sulfide Regulates SERCA2a Ubiquitylation via Muscle RING Finger-1 S-Sulfhydration to Affect Cardiac Contractility in db/db Mice.
Peng S; Zhao D; Li Q; Wang M; Zhang S; Pang K; Huang J; Lu F; Chen H; Zhang W
Cells; 2022 Nov; 11(21):. PubMed ID: 36359861
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
[TBL] [Abstract][Full Text] [Related]
12. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Falcão-Pires I; Leite-Moreira AF
Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide postconditioning rendered cardioprotection against myocardial ischemia-reperfusion injury is compromised in rats with diabetic cardiomyopathy.
Ansari M; Prem PN; Kurian GA
Microvasc Res; 2022 May; 141():104322. PubMed ID: 35063446
[TBL] [Abstract][Full Text] [Related]
14. Disruption of energy utilization in diabetic cardiomyopathy; a mini review.
Nirengi S; Peres Valgas da Silva C; Stanford KI
Curr Opin Pharmacol; 2020 Oct; 54():82-90. PubMed ID: 32980777
[TBL] [Abstract][Full Text] [Related]
15. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
16. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress.
Barr LA; Shimizu Y; Lambert JP; Nicholson CK; Calvert JW
Nitric Oxide; 2015 Apr; 46():145-56. PubMed ID: 25575644
[TBL] [Abstract][Full Text] [Related]
18. Exogenous H
Yang F; Yu X; Li T; Wu J; Zhao Y; Liu J; Sun A; Dong S; Wu J; Zhong X; Xu C; Lu F; Zhang W
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E190-E203. PubMed ID: 27998959
[TBL] [Abstract][Full Text] [Related]
19. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
